257 related articles for article (PubMed ID: 30694001)
1. Performance of a 31-gene expression profile test in cutaneous melanomas of the head and neck.
Gastman BR; Zager JS; Messina JL; Cook RW; Covington KR; Middlebrook B; Gerami P; Wayne JD; Leachman S; Vetto JT
Head Neck; 2019 Apr; 41(4):871-879. PubMed ID: 30694001
[TBL] [Abstract][Full Text] [Related]
2. Incidence and location of positive nonsentinel lymph nodes in head and neck melanoma.
Gyorki DE; Boyle JO; Ganly I; Morris L; Shaha AR; Singh B; Wong RJ; Shah JP; Busam K; Kraus D; Coit DG; Patel S
Eur J Surg Oncol; 2014 Mar; 40(3):305-10. PubMed ID: 24361245
[TBL] [Abstract][Full Text] [Related]
3. Prognostic markers in metastatic cutaneous squamous cell carcinoma of the head and neck.
Hirshoren N; Danne J; Dixon BJ; Magarey M; Kleid S; Webb A; Tiong A; Corry J; Gyorki D
Head Neck; 2017 Apr; 39(4):772-778. PubMed ID: 28199044
[TBL] [Abstract][Full Text] [Related]
4. Sentinel lymph node biopsy in cutaneous melanoma of the head and neck using the indocyanine green SPY Elite system.
Vahabzadeh-Hagh AM; Blackwell KE; Abemayor E; St John MA
Am J Otolaryngol; 2018; 39(5):485-488. PubMed ID: 29803536
[TBL] [Abstract][Full Text] [Related]
5. Performance of a prognostic 31-gene expression profile in an independent cohort of 523 cutaneous melanoma patients.
Zager JS; Gastman BR; Leachman S; Gonzalez RC; Fleming MD; Ferris LK; Ho J; Miller AR; Cook RW; Covington KR; Meldi-Plasseraud K; Middlebrook B; Kaminester LH; Greisinger A; Estrada SI; Pariser DM; Cranmer LD; Messina JL; Vetto JT; Wayne JD; Delman KA; Lawson DH; Gerami P
BMC Cancer; 2018 Feb; 18(1):130. PubMed ID: 29402264
[TBL] [Abstract][Full Text] [Related]
6. Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck.
May MM; Lohse CM; Moore EJ; Price DL; Van Abel KM; Brewer JD; Janus JR
Int J Dermatol; 2019 Oct; 58(10):1184-1190. PubMed ID: 30968948
[TBL] [Abstract][Full Text] [Related]
7. [Cutaneous malignant melanoma in the area of the head and neck with intermediate tumor thickness: does primary site have prognostic relevance?].
Wenzel S; Metternich FU; Sagowski C; Neuber K; Kehrl W
Laryngorhinootologie; 2001 Jun; 80(6):313-7. PubMed ID: 11475610
[TBL] [Abstract][Full Text] [Related]
8. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
9. Recurrence of cutaneous melanoma of the head and neck after negative sentinel lymph node biopsy.
Davis-Malesevich MV; Goepfert R; Kubik M; Roberts DB; Myers JN; Kupferman ME
Head Neck; 2015 Aug; 37(8):1116-21. PubMed ID: 24764188
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy in the management of cutaneous head and neck melanoma.
Carlson GW; Murray DR; Lyles RH; Hestley A; Cohen C
Plast Reconstr Surg; 2005 Mar; 115(3):721-8. PubMed ID: 15731669
[TBL] [Abstract][Full Text] [Related]
11. Selective Sentinel Lymph Node Dissection in Lower Extremity Melanoma.
Miranda SG; Parrett BM; Li RR; Lee G; Chang T; Fadaki N; Cardona-Huerta S; Cleaver JE; Kashani-Sabet M; Leong SP
Plast Reconstr Surg; 2016 Mar; 137(3):1031-1038. PubMed ID: 26809037
[TBL] [Abstract][Full Text] [Related]
12. Number of Excised Lymph Nodes Has No Impact on Relapse and Survival in Patients With Stage III Melanoma.
Tas F; Erturk K
Ann Plast Surg; 2019 Oct; 83(4):455-458. PubMed ID: 31524742
[TBL] [Abstract][Full Text] [Related]
13. Patterns of recurrence and retreatment outcomes among clinical stage I and II head and neck melanoma patients.
Namin AW; Cornell GE; Thombs LA; Zitsch RP
Head Neck; 2019 May; 41(5):1304-1311. PubMed ID: 30629324
[TBL] [Abstract][Full Text] [Related]
14. Is sex an independent prognostic factor in cutaneous head and neck melanoma?
Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ
Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966
[TBL] [Abstract][Full Text] [Related]
15. Risk and Survival of Patients with Head and Neck Cutaneous Melanoma: National Perspective.
Al-Qurayshi Z; Hassan M; Srivastav S; Sperry S; Pagedar N; Hamner J; Kandil E
Oncology; 2017; 93(1):18-28. PubMed ID: 28423377
[TBL] [Abstract][Full Text] [Related]
16. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma.
Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR
Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymph node staging of cutaneous melanoma: predictors and outcomes.
Ellis MC; Weerasinghe R; Corless CL; Vetto JT
Am J Surg; 2010 May; 199(5):663-8. PubMed ID: 20466113
[TBL] [Abstract][Full Text] [Related]
18. A prospective study of intraoperative lymphatic mapping for head and neck cutaneous melanoma.
Eicher SA; Clayman GL; Myers JN; Gillenwater AM
Arch Otolaryngol Head Neck Surg; 2002 Mar; 128(3):241-6. PubMed ID: 11886337
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant radiotherapy versus observation alone for patients at risk of lymph-node field relapse after therapeutic lymphadenectomy for melanoma: a randomised trial.
Burmeister BH; Henderson MA; Ainslie J; Fisher R; Di Iulio J; Smithers BM; Hong A; Shannon K; Scolyer RA; Carruthers S; Coventry BJ; Babington S; Duprat J; Hoekstra HJ; Thompson JF
Lancet Oncol; 2012 Jun; 13(6):589-97. PubMed ID: 22575589
[TBL] [Abstract][Full Text] [Related]
20. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]